Prenatal diagnosis of genetic abnormalities:
Has it really moved to the first trimester? OBJECTIVE: Advances in genetic screening can identify patients at high risk for common genetic conditions early in pregnancy, and can facilitate early diagnosis and abortion. Less common abnormalities might only be diagnosed when invasive testing is performed after structural abnormalities are identified. Our objective was to compare gestational ages at diagnosis and abortion for genetic abnormalities identified based on screening and other genetic abnormalities. STUDY DESIGN: All prenatal diagnostic procedures in our department from 2012-2017 were reviewed, and singleton pregnancies terminated following diagnosis of genetic abnormalities were identified. Cases diagnosed as the result of screening tests were compared to remaining cases. Specific conditions were considered "screened for" if they can be suspected by NIPT, biochemistry, carrier screening, or if the patient was a known carrier of a single gene disorder. Since abnormal NT is associated with many genetic disorders, abnormal karyotype, microarray, or Noonan syndrome associated with abnormal NT were considered "screened for". Gestational age at abortion was the primary outcome. Fisher's exact test and MannWhitney U were used for statistical comparison. RESULTS: 267 cases were included. 230 (86%) of abortions were performed for genetic disorders considered screened for, with 209 (91%) of these for karyotype abnormalities, 9 (4%) for microarray abnormalities and 12 (5%) for single gene disorders. 37 (14%) of abortions were performed for conditions not included in screening or with any family history, with 12 (32%) of those for karyotype abnormalities, 18 (49%) for microarray abnormalities and 7 (19%) for single gene disorders. Invasive testing and abortion occurred at earlier median gestational age for those with conditions that were screened for: 12w2d vs. 15w5d; p ¼<.001, and 13w5d vs. 20w0d; p¼<.001. (Table 1 ) CONCLUSION: Most abortions were for common chromosomal abnormalities and single gene disorders that can be suspected early in pregnancy. About 1 in 7 were performed for less common conditions in patients not known to be at risk. Because many structural abnormalities associated with rare genetic conditions will not be identified until the second trimester, prenatal diagnosis and abortion occurred significantly later. Physicians and patients should be aware of the limitations of genetic screening, particularly when restrictions in abortion access can limit options in the second trimester. 
OBJECTIVE:
To assess the frequency of familial versus de novo chromosome inversions during prenatal diagnosis and determine their clinical significance. STUDY DESIGN: A retrospective analysis of prenatally diagnosed inversions from a large reference lab database was performed. The data was reviewed for the type and frequency of various types of inversions, as well as their inheritance pattern. Variant inversion 9 was excluded. RESULTS: A total of 4088 (0.3 %) inversions were identified in a data set of 1.3 million invasive diagnostic procedures. Pericentric inversions accounted for 73% of the inversions (n¼2987), and the remaining 27% were paracentric. Common inversions involving chromosomes 1, 2, 10, and Y accounted for 46.7% of the total inversions (1911/4088) . The most frequently identified inversion was inversion 2, inv2(p11q13), accounting for 23% of all inversions. The indications for invasive testing were as follows: advanced maternal age 1941 (47.5%), abnormal aneuploidy screen 935(22.9%), abnormal ultrasound findings 617(15%), previous chromosomal abnormality 449(11%), family history of a significant genetic disorder 69(1.7%), other indication 68(1.7%), and no indication in 10 cases. Excluding the common inversion group, mode of inheritance was available in 81% of cases (1767/2177), with 92% of inversions being inherited (1633/1767). There was a slight preponderance of maternal inheritance (53%). When an abnormal ultrasound was the Poster Session V ajog.org 
